Alon Ben-Noon (@noonalon) 's Twitter Profile
Alon Ben-Noon

@noonalon

Leading NeuroSense Therapeutics (Nasdaq: $NRSN), a Clinical stage Biotech company, accelerating therapies for ALS and Neurodegenerative diseases.

ID: 1213345396023390208

linkhttps://www.neurosense-tx.com/ calendar_today04-01-2020 06:24:32

284 Tweet

1,1K Followers

2,2K Following

Alon Ben-Noon (@noonalon) 's Twitter Profile Photo
Alon Ben-Noon
@noonalon

a year ago

$nrsn I'm excited to share these news. Across the board we see positive impact on patient's lives. Soon enough we'll be updating on the NfLs which are an important biomarker that reflects disease progression. NfLs are valued highly by the FDA and of course - by us too.